PARP1 inhibitor niraparib exerts synergistic antimyeloma effect with bortezomib through inducing DNA damage and inhibiting DNA repair

Haiyan Zhang(Nantong University), Xiequn Chen(Northwest University), Jinpeng Wu(Lawrence Berkeley National Laboratory), Lining Li(Northwest University), Mengdi Cheng(Sichuan University), Hongbo Liu(Northwest University)
Free Radical Biology and Medicine
December 28, 2024
Cited by 5


Related Papers